Selective dopamine neurotoxicity by an industrial chemical: an environmental cause of Parkinson's disease? (Q48549862)

12 February 2018

title

Selective dopamine neurotoxicity by an industrial chemical: an environmental cause of Parkinson's disease? (English)

1 reference

12 February 2018

1 reference

1 reference

Masalha R

1

1 reference

12 February 2018

Herishanu Y

series ordinal

2

1 reference

12 February 2018

Alfahel-Kakunda A

series ordinal

3

1 reference

12 February 2018

Silverman WF

series ordinal

4

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

12 February 2018

volume

774

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

260-264

1 reference

12 February 2018

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

Clustering of Parkinson's disease points to environmental etiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: Quantification using the rotational model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

The role of environmental toxins in the etiology of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981717-9

10.1016/S0006-8993(97)81717-9

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018